Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia

The goal of this clinical trial is to demonstrate GL-2045 safety and efficacy proof of concept by demonstrating intravenous immunoglobulin (IVig)-like platelet responses in adult patients with Immune Thrombocytopenia (ITP).

Participants needed: 42
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Gliknik Inc.Updated: May 26, 2026Locations: 1
Eligibility criteria

Male or female between 18 and 80 years of age with ITP or certain limited ITP co... [+4]

Any serious adverse event (SAE) with prior IVIg dosing. [+5]

Read more
Status: Recruiting

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

The purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GL-0719 following single intravenous (IV) and subcutaneous injection (SC) doses in healthy adult male and female subjects. In addition, safety, tolerability, PK, and pilot efficacy biomarkers will be evaluated in subjects with cold agglutinin disease (CAD).

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Gliknik Inc.Updated: Mar 6, 2026Locations: 1
Eligibility criteria

Healthy female or male subjects who, at the time of screening, are between the a... [+13]

History of any clinically significant (as determined by the investigator) cardia... [+13]

Read more